Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan. The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan. Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan. The gross margin for the c...
To reduce the negative list for foreign investment access, expand the opening up for telecommunication and healthcare sectors, and scrap the negative list of manufacturing. To expand access to foreign financial institutions in the banking and insurance sectors. To expand the business scope for the domestic bond market, allow foreign financial institutions to underwrite onshore bonds. To expand pilot projects for Limited Partners...
ln a press release Wednesday afternoon, the Biotechnology Innovation Organization said it will take steps to separate from WuXi—AppTec regarding membership and support the BIOSECURE Act. $薬明生物(02269.HK)$$無錫薬明康徳(02359.HK)$
薬明生物に関するコメント
JUST IN:
NBS:
Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.
Some 29 out of China's 41 main industries saw profits rise in the first two months.
$アリババ・グループ・ホールディング(BABA.US)$$阿里巴巴集団(09988.HK)$$テンセント(00700.HK)$$小米集団(01810.HK)$$京東(09618.HK)$$BIDU-SW(09888.HK)$$BYD(01211.HK)$$会徳豊(00020.HK)$$China Petroleum & Chemical Corporation(600028.SH)$
Wuxi Biologics Earnings Report: FY Net Income Misses Estimates Despite Revenue Surpassing Predictions
The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan.
Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan.
The gross margin for the c...
HSI Closes at 16,473, Down 25 pts
Active Heavyweights:
$美団点評(03690.HK)$ closed at $93.3, up 5.7%
$香港証券取引所(00388.HK)$ closed at $231.6, down 2.8%
$平安保険(02318.HK)$ closed at $32.65, down 2.4%
$友邦保険(01299.HK)$ closed at $54.8, down 2.1%
$阿里巴巴集団(09988.HK)$ closed at...
$Hang Seng H-Share Index ETF(02828.HK)$$Hang Seng Index(800000.HK)$
China's State Council on further foreign capital attractions:
To expand access to foreign financial institutions in the banking and insurance sectors.
To expand the business scope for the domestic bond market, allow foreign financial institutions to underwrite onshore bonds.
To expand pilot projects for Limited Partners...
HSI Opens 109 pts Lower as WUXI Series Slip
$無錫薬明康徳(02359.HK)$ , whose net profit rose 21% in 2023, delayed two placing-funded investment projects by 2 years to the end of 2025, and its share price lost 2.8% to $41.55, while its sa...
恒生大底 show hand
HKD505.7M Southbound Trading Net Outflow from MEITUAN-W
There was HKD505.7 million, HKD372.6 million and HKD147.1 million Southbound Trading net outflow from $美団点評(03690.HK)$ , $テンセント(00700.HK)$ and $中国海洋石油(00883.HK)$ .
For $SH->HK コネクト(GangGuTong.HK)$ , $中国銀行(03988.HK)$ was the most active stock with highest net inflow of ...
$無錫薬明康徳(02359.HK)$ tumbled by 5% and $薬明生物(02269.HK)$ was down 6.7%. Biotechnology Innovation Organization revised the announcement to WuXi Apptec proactively ending its relationship with BIO.
The share price of Wuxi AppTec once tumbled by over 8% in Hong Kong on Thursday.
$薬明生物(02269.HK)$$無錫薬明康徳(02359.HK)$
まだコメントはありません